Difference between revisions of "Imetelstat (Rytelo)"
Jump to navigation
Jump to search
m |
m |
||
| Line 4: | Line 4: | ||
==Preliminary data== | ==Preliminary data== | ||
| + | ===[[Myelofibrosis]]=== | ||
# '''Abstract:''' Kebede Begna, Rebecca R. Laborde, Mrinal M Patnaik, Terra L Lasho, Darci Zblewski, Christy Finke, Lauren Schimek, Betsy R. LaPlant, Curtis A. Hanson, Monic J. Stuart, Animesh Pardanani. Imetelstat, a Telomerase Inhibitor, Induces Morphologic and Molecular Remissions In Myelofibrosis and Reversal Of Bone Marrow Fibrosis. Blood Nov 2013,122(21)662 [http://bloodjournal.hematologylibrary.org/content/122/21/662 link to original abstract] | # '''Abstract:''' Kebede Begna, Rebecca R. Laborde, Mrinal M Patnaik, Terra L Lasho, Darci Zblewski, Christy Finke, Lauren Schimek, Betsy R. LaPlant, Curtis A. Hanson, Monic J. Stuart, Animesh Pardanani. Imetelstat, a Telomerase Inhibitor, Induces Morphologic and Molecular Remissions In Myelofibrosis and Reversal Of Bone Marrow Fibrosis. Blood Nov 2013,122(21)662 [http://bloodjournal.hematologylibrary.org/content/122/21/662 link to original abstract] | ||
| + | |||
| + | [[Category:Drug index]] | ||
| + | [[Category:Chemotherapy]] | ||
| + | |||
| + | [[Category:Telomerase inhibitors]] | ||
| + | |||
| + | [[Category:Myelofibrosis medications]] | ||
[[Category:Investigational]] | [[Category:Investigational]] | ||
| − | |||
Revision as of 04:49, 23 November 2014
Mechanism of action
A lipid-conjugated oligonucleotide inhibitor of human telomerase. Link to company website
Preliminary data
Myelofibrosis
- Abstract: Kebede Begna, Rebecca R. Laborde, Mrinal M Patnaik, Terra L Lasho, Darci Zblewski, Christy Finke, Lauren Schimek, Betsy R. LaPlant, Curtis A. Hanson, Monic J. Stuart, Animesh Pardanani. Imetelstat, a Telomerase Inhibitor, Induces Morphologic and Molecular Remissions In Myelofibrosis and Reversal Of Bone Marrow Fibrosis. Blood Nov 2013,122(21)662 link to original abstract